期刊文献+

温州地区急性白血病儿童CYP3A5基因多态性研究

The relationship between the CYP3A5 genetic polymorphisms and susceptibility to childhood acute leukemia
下载PDF
导出
摘要 目的:探讨温州地区汉族人群细胞色素P450-3A5(CYP3A5)基因多态性与儿童急性白血病(AL)易感性的关系。方法:采用限制性片段长度多态性聚合酶链反应(PCR-RFLP)技术和PCR产物测序方法,检测119例AL患儿(病例组)和106例对照儿童(对照组)的CYP3A5-6986位点基因型分布及等位基因频率,并结合既往发表的文献进行温州与苏州不同地区间的比较。结果:1对照组与急性淋巴细胞白血病(ALL)组、急性髓细胞白血病(AML)组的基因型分布差异存在统计学意义(P<0.05)。2病例组G位点的基因频率高于对照组(P<0.05)。3按性别因素分层分析,儿童白血病的遗传易感性存在性别差异。4温州、苏州两个地区AL患儿的基因型分布差异无统计学意义(P>0.05)。结论:CYP3A5基因6986位点AG多态性可能与中国南方汉族人群男性白血病患儿的遗传易感性相关联。 Objective: To study the relationship of CYP3A5-6986A/G polymorphism and acute leukemia in Han population of southern Chinese. Methods: The methods ofpolymerase chain reaction-restriction fragment length polymorphism and PCR sequence were used, the polymorphism of the CYP3A5 gene was detected in both 119 acute leukemia patients and 106 control subjects. Results:① The differences in the distribution of genotype of CYP3A5-6986A/G between the patients and the controls were significant. ②The genetic frequency of G allele in ALL and in AML were all higher than that in controls. ③The results by gender stratification showed that the boy individuals with CYP3A5 variant genotype were more susceptible to childhood leukemia with a 2.65-fold increased risk compared to the individuals with wild genotype. ④There was no variation of CYP3A5-6986A/G polymorphism on acute leukemia patients between Wenzhou and Suzhou area. Conclusion: The CYP3A5 genetic polymorphism may be associated with the susceptibility of acute leukemia in Han population of male southern Chinese.
出处 《温州医学院学报》 CAS 2014年第10期733-736,共4页 Journal of Wenzhou Medical College
基金 温州市科技局科研基金资助项目(Y20080180)
关键词 白血病 儿童 基因多态性 易感性 细胞色素P450-3A5 leukemia children genetic polymorphism susceptibility cytochrome P450-3A5
  • 相关文献

参考文献13

  • 1Canalle R, Burim RV, Tone LG, et al. Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia[J]. Environ Mol Mutagen, 2004, 43(2): 100-109.
  • 2Krajinovic M, Labuda D, Sinnett D, et al. Childhood acute lymphoblastic leukemia: genetic determinants of susceptibility and disease outcome[J]. Rev Environ Health, 2001, 16 (4): 263-279.
  • 3Kuehl P, Zhang J, Lin Y, et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression[J]. Nat Genet, 2001, 27(4): 383-391.
  • 4Simpson D, Noble S. Tacrolimus ointment: A review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions[J]. Drugs, 2005, 65(6): 827-858.
  • 5Li D, Zhang GL, Lou YQ, et al. Genetic polymorphisms in MDRI and CYP3A5 and MDRI haplotype in mainland Chinese Han, Uygur and Kacakh ethnic groups[J]. J Clin Pharm Ther, 2007, 32(1): 89-95.
  • 6van Schaik RH, van der Heiden IP, van den Anker IN, et al. CYP3A5 variant allele frequencies in Dutch Caucasians[J] . Clin Chern, 2002, 48(10): 1668-1671.
  • 7Pakakasama S, Mukda E, Sasanakui W, et al. Polymorphisms of drug metabolizing enzymes and risk of acute lymphoblastic leukemia[J]. Am J Hematol, 2005, 79(3): 202-205.
  • 8Liu TC, Lin SF, Chen TP, et al. Polymorphism analysis of CYP3A5 in myeloid leukemia[J]. Oncol Rep, 2002, 9(2): 327-329.
  • 9Hu YF, He J, Chen GL, et al. CYP3A5*3 and CYP3A4*18 single nucleotide polymorphisms in a Chinese population[J]. Clin ChimActa, 2005, 353(1-2): 187-192.
  • 10Sinues B, Mayayo E, Fanle A, et al. Effect of growth hormone deficiency and rhGH replacement therapy on the 6betahydroxycortisollfree cortisol ratio, a marker of CYP3A activity, in growth hormone-deficient children[J]. Eur J Clin Pharmacol, 2004, 60(8): 559-564.

二级参考文献16

  • 1王汉平,毛平,谢健晋,许艳丽,莫文健,杜庆华,朱志刚.细胞色素P-450 3A5基因类型影响造血干细胞移植患者血环孢素浓度[J].中华器官移植杂志,2005,26(4):207-209. 被引量:5
  • 2Felix CA, Wakler AH, Langer BJ, et al. Association of CYP3A4 genotype with treatment-related leukemia. Proc Natl Acad SCI USA,1998, 95:13176-13181.
  • 3van Schaik RH, van der Heiden IP, wan den Anker JN,et al. CYP3A5 variant allele frequencies in Dutch Caucasians. Clin C hem, 2002,48 : 1668 -1671.
  • 4Rothman N, Wacholder S, Caporaso NE, et al. The use of common genetic polymorphisms to enhance the epidemiologic study of environmental carcinogens. Biochim Biophys Acta,2001,1471 : C1-C10.
  • 5Jatinder KL,Yvonne SL, Thummel KE, et al. Genetic contribution to variable human CYP3A-mediated metabolism. Advanced drug delivery reviews, 2002,54 : 1271-1294.
  • 6Wojnowski L. Genetics of the variable expression of CYP3A in humans. Ther Drug Monit, 2004,26 : 192-199.
  • 7Kuehl P, Chang J, Lin Y, et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet ,2001,27 : 383-391.
  • 8Pakakasama S, Mukda E, Sasanakui W, et al. Polymorphisms of drug metabolizing enzymes and risk of acute lymphoblastic leukemia. Am J Hematol,2005 ,79 :202-205.
  • 9Goh BC, Lee SC, Wang Lz, et al. Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategies. J Clin Oncol, 2002,20 : 3683 -3690.
  • 10de-Wildt SN, Kearns GL, Leeder JS, et al. Cytochrome P450 3A: ontogeny and drug disposition. Clin Pharmacokinet, 1999;37:485-505.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部